Creative Biolabs offers specialized thymic stromal lymphopoietin (TSLP) assay services to accelerate the development of targeted cancer therapies and diagnostics. We utilize advanced technology and expertise to meticulously investigate the complex and often dual role of the TSLP/TSLPR axis in tumor immunity. This cytokine signaling pathway can either promote anti-tumor responses or support tumor growth and metastasis, making it a critical area for study. Our services provide the actionable data needed to precisely define the role of TSLP in your specific cancer model.
TSLP is an epithelial-derived cytokine that plays a key role in barrier immunity and allergic inflammation by activating dendritic cells, mast cells, and CD4+ T cells via a receptor complex of TSLPR and IL-7Rα. Beyond its role in atopic diseases, TSLP is increasingly implicated in cancer. It promotes a Th2-dominant tumor microenvironment, which can suppress antitumor immunity. Elevated TSLP levels in cancers like pancreatic and breast cancer are linked to enhanced tumor growth and metastasis, highlighting its potential as a therapeutic target in oncology.
Our portfolio encompasses a wide range of analytical services, tailored to meet the diverse needs of preclinical research. We offer quantitative assays, such as ELISA kits, for the precise measurement of TSLP concentrations in various biological matrices, including serum, plasma, and cell culture supernatants. Our kits are developed with high specificity and sensitivity to ensure reliable and reproducible results. Beyond simple quantitation, our services delve into the functional aspects of TSLP signaling:
Looking for a partner for your oncology research? Contact us to discuss your specific model.
This comprehensive review explores the dual and context-dependent roles of thymic stromal lymphopoietin (TSLP) in cancer. Primarily known as an epithelial-derived alarmin cytokine driving type 2 inflammation in allergic diseases, TSLP signaling through its heterodimeric receptor (TSLPR/IL-7Rα) also significantly influences the tumor microenvironment. The article synthesizes evidence showing TSLP can be protumorigenic—promoting angiogenesis, metastasis, and immunosuppressive Th2/Treg responses in cancers like pancreatic, colorectal, and breast cancer—or antitumorigenic, by enhancing CD4+ T cell-mediated immunity in other contexts. It highlights the recent approval of the anti-TSLP antibody tezepelumab and underscores the urgent need to understand the complex, often contradictory functions of TSLP and its isoforms to guide future cancer immunotherapies.
Fig.1 Schematic diagram of TSLP-mediated receptor activation and intracellular signaling. 1
Creative Biolabs provides a comprehensive TSLP assay portfolio service to support your research and drug discovery efforts. Leveraging deep expertise and advanced technology, we offer highly sensitive and specific quantitative assays—including ELISA kits—to accurately measure TSLP levels in serum, plasma, and cell culture samples. Our end-to-end solutions are designed to deliver reliable, reproducible data, helping you gain a mechanistic understanding of the TSLP pathway and evaluate potential TSLP-targeted therapies. We partner closely with you to ensure scientific rigor and accelerate your project from preclinical to clinical stages.
Experience the Creative Biolabs Advantage - Get a Quote Today
A1: Our TSLP assay service offers more than simple quantitation. We provide comprehensive functional and signaling pathway analysis, offering a deeper understanding of TSLP's biological activity and how your therapeutic candidate modulates it, all with validated results and expert data interpretation.
A2: Absolutely. Our high-throughput screening platforms are optimized to efficiently screen large compound libraries. We can design a customized screening assay, such as a reporter assay, to identify potential TSLP inhibitors and provide you with a ranked list of promising hits.
A3: Yes. While TSLP is well-known in allergic disease, its role in oncology is an exciting and emerging area of research. We can tailor our TSLP functional assays to a variety of cancer cell lines and models to investigate their pro- or anti-tumor effects.
In addition to our TSLP assay portfolio, Creative Biolabs offers a suite of complementary services to support your research:
Creative Biolabs provides comprehensive and professional services for overexpressed cytokine secretion kinetics analysis. With extensive experience and an advanced platform, we assist clients in obtaining satisfactory data for different cancer therapies.
Learn More →Creative Biolabs provides an unparalleled platform for chemokine production measurement assays. Our highly skilled scientists use advanced technology and a powerful service to meet various customer needs, ensuring efficient and accurate results for their projects.
Learn More →To discuss your project in detail and learn more about how we can help you achieve your research goals, please reach out to our team of experts.
If you are interested in our service, please contact us or send us an email.
Reference